Charles Esther
Chronic care startup Omada Health filed its S-1 at the start of May 2025, officially entering the race to go public.
The announcement comes alongside the launch of a suite of AI-powered nutrition tools aimed at transforming patient care across chronic conditions.
This bold move places Omada at the heart of the booming “food as medicine” market.
OmadaSpark Brings Nutrition Intelligence to Patients
The company’s newest product, OmadaSpark, is a virtual AI agent designed to deliver personalised nutrition guidance.
It supports patients through goal-setting sessions and education related to food choices.
This new tool is the core of Omada’s “nutritional intelligence” initiative.
It’s meant to help patients adopt long-lasting behaviour changes related to diet and overall wellness.
Entering a Booming Health Tech Market
Omada’s new features align with growing national interest in nutritional health.
US health leaders and the Department of Health and Human Services are advocating for preventive strategies through food and lifestyle changes.
At the same time, the popularity of GLP-1 drugs like Ozempic is reshaping how the public approaches weight loss.
Investors are backing startups that promote better nutrition, such as Nourish and Fay Nutrition.
Omada is seizing this momentum to drive new growth.
Expanding Patient Access Through Smart Features
The new tools are being rolled out across all of Omada’s care tracks.
These include diabetes, hypertension, and obesity.
The features allow patients to ask nutrition questions, track meals, and monitor water intake directly in Omada’s mobile app.
The app supports food logging through barcode scanning and even meal photo uploads.
These capabilities make OmadaSpark the first AI tool within the app designed for direct patient interaction.
Fine-Tuned AI Built for Real Health Outcomes
Dr. Justin Wu, Omada’s Vice President of Clinical Innovation and Quality, stated that OmadaSpark has been refined using internal clinical expertise.
It also incorporates guidelines from agencies like the United States Department of Agriculture.
This ensures that the AI provides not just accurate responses but responsible guidance tailored to each patient.
Anti-Diet Approach in a Calorie-Obsessed World
Omada’s leadership emphasises that their approach is anti-diet and rooted in holistic well-being.
Unlike traditional weight-loss apps, the new tools do not encourage strict calorie counting.
Instead, Omada promotes nutrient-dense eating habits and customises advice based on individual health data, lifestyle, and medication status — including those on GLP-1s.
Dr. Wu explained that Omada aims to remove guilt around eating and give patients the freedom to make positive choices.
Addressing Emotional and Disordered Eating
Omada understands the sensitivity needed when addressing eating habits.
As such, OmadaSpark’s goal-setting tools are being rolled out initially only to users who report concerns with emotional eating.
This controlled rollout ensures that vulnerable users receive appropriate support.
Data from these sessions will also be shared with human care teams for deeper conversations and personalised guidance.
Omada Prepares for Public Debut Amid Market Shifts
Omada Health is one of only two digital health companies publicly planning IPOs in 2025, alongside Hinge Health.
The company reported nearly $170 million in revenue in 2024 — a 38% year-over-year increase — with a gross margin of 60%.
Despite not being profitable yet, Omada’s $47 million net loss is an improvement over previous years, signaling a path to sustainability.
The company previously raised $192 million in a Series E round in 2022, led by Fidelity, pushing its valuation beyond $1 billion.
Omada plans to list on Nasdaq under the ticker symbol OMDA.
